Medicare Enrolled

Dr. Angela Barbera, M.D.

Ophthalmology · Wyomissing, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1 GRANITE POINT DR STE 100, Wyomissing, PA 19610
6103781344
In practice since 2009 (17 years)
NPI: 1356577340 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barbera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barbera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Barbera

Dr. Angela Barbera is an ophthalmology specialist in Wyomissing, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Barbera performed 16,968 Medicare services across 2,594 unique beneficiaries.

Between the years covered by Open Payments, Dr. Barbera received a total of $2,482 from 22 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Barbera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 6% volume in PA $2,482 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,968
Medicare services
Top 6% in PA for ophthalmology
2,594
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~998 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
10,500 $28 $45
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,827 $30 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
966 $68 $95
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
954 $88 $626
Aflibercept eye injection (Eylea) 944 $689 $1,245
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
541 $68 $170
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
335 $67 $250
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
259 $159 $250
Injection, ranibizumab, 0.1 mg 186 $168 $409
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
132 $93 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
132 $91 $175
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
41 $16 $75
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $106 $220
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
29 $60 $120
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
25 $27 $125
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
17 $33 $330
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
15 $105 $230
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
13 $42 $100
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
12 $867 $4,600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,482
Total received (2018-2024)
Avg $355/year across 7 years
Top 32% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,452 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$932
2023
$764
2022
$602
2021
$50
2020
$48
2019
$56
2018
$30

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$249
Regeneron Healthcare Solutions, Inc.
$157
Astellas Pharma Global Development
$150
Alimera Sciences, Inc.
$77
Genentech USA, Inc.
$74
Astellas Pharma US Inc
$71
Apellis Pharmaceuticals, Inc.
$57
Alcon Vision LLC
$38
Merz Pharmaceuticals, LLC
$31
Tarsus Pharmaceuticals, Inc.
$15
Bausch & Lomb Americas Inc.
$13
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$489
ABBVIE INC.
$350
Regeneron Healthcare Solutions, Inc.
$303
AbbVie Inc.
$209
EyePoint Pharmaceuticals US, Inc.
$167
Alimera Sciences, Inc.
$155
Astellas Pharma Global Development
$150
Alcon Vision LLC
$137
Astellas Pharma US Inc
$91
GLAUKOS CORPORATION
$82
Apellis Pharmaceuticals, Inc.
$79
Novartis Pharmaceuticals Corporation
$77
Merz Pharmaceuticals, LLC
$31
Allergan Inc.
$30
Coherus Biosciences Inc.
$24
Genentech, Inc.
$22
Rayner Intraocular Lenses Limited
$19
Spark Therapeutics, Inc.
$15
Tarsus Pharmaceuticals, Inc.
$15
Bausch & Lomb Americas Inc.
$13
Johnson & Johnson Surgical Vision, Inc.
$13
Allergan, Inc.
$12
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
BEOVU · CATALYS SYSTEM · Cimerli · Clareon · DURYSTA · EYLEA · EYLEA HD · HYDRUS Microstent · IACCESS · ILUVIEN · Izervay · LUMIGAN · LUXTURNA · Lucentis · OZURDEX · Omidria · Rocklatan · Syfovre · VABYSMO · VUITY · VYZULTA · Vabysmo · XDEMVY · XIIDRA · Xeomin · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Wyomissing?
Compare ophthalmologists in the Wyomissing area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
40
Per 100K population
9.3
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Barbera is a mixed practice specialist, with above-average Medicare volume (top 6% in PA), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Barbera experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Barbera performed 10,500 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barbera receive payments from pharmaceutical companies?
Yes. Dr. Barbera received a total of $2,482 from 22 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barbera's costs compare to other ophthalmologists in Wyomissing?
Dr. Barbera's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barbera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →